The North America Cancer Biomarkers Market continues to lead the global landscape, supported by advanced healthcare infrastructure, strong investment in cancer research, and the widespread adoption of precision medicine. The region has witnessed significant advancements in molecular diagnostics and biomarker-based testing, enabling earlier cancer detection and more personalized treatment...